Výsledky vyhledávání - "Matthieu Beuvelet"

Akademický článek

Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes

Autor: Alexia Kieffer, Matthieu Beuvelet, Gerald Moncayo, Mersha Chetty, Aditya Sardesai, Robert Musci, Richard Hudson

Publikováno v: Infectious Diseases and Therapy, Vol 13, Iss 10, Pp 2135-2153 (2024)

Abstract Introduction Respiratory syncytial virus (RSV) leads to significant morbidity in newborn infants in the United Kingdom (UK). Nirsevimab, a long-acting monoclonal antibody, received approval from the European Medicines Agency and has been lic

Externí odkaz: https://doaj.org/article/5564bff80f2a41beaf6fcbd72e81efd2

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Modelling the potential clinical and economic impact of universal immunisation with nirsevimab versus standard of practice for protecting all neonates and infants in their first respiratory syncytial virus season in Spain

Autor: Ruth Gil-Prieto, Jaime Jesus Pérez, Georgina Drago, Alexia Kieffer, Julie Roïz, Paulina Kazmierska, Aditya Sardesai, Solène de Boisvilliers, Juan Luis López-Belmonte, Matthieu Beuvelet, Javier Alvarez Aldean

Publikováno v: BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)

Abstract Background Respiratory syncytial virus (RSV) is associated with substantial morbidity among infants. This study modelled the potential public health and economic impact of nirsevimab, a long-acting monoclonal antibody, as an immunoprophylact

Externí odkaz: https://doaj.org/article/666c4cefd3bd45338d8cbfd55b48a6b8

Zobrazit plný text záznamu

Plný text ve formátu HTML

Response to Fullarton et al

Autor: Alexia Kieffer, Matthieu Beuvelet, Aditya Sardesai, Robert Musci, Sandra Milev, Jason K H Lee

Publikováno v: The Journal of infectious diseases.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac0b3743565193fc7a666de63343be86
https://pubmed.ncbi.nlm.nih.gov/36519404

Zobrazit plný text záznamu

Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model

Autor: Alexia Kieffer, Matthieu Beuvelet, Aditya Sardesai, Robert Musci, Sandra Milev, Julie Roiz, Jason K H Lee

Publikováno v: The Journal of infectious diseases. 226(Suppl 2)

Background Respiratory syncytial virus (RSV) is associated with substantial morbidity in the United States, especially among infants. Nirsevimab, an investigational long-acting monoclonal antibody, was evaluated as an immunoprophylactic strategy for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf50c2562202d49684b7fa5d62b6c299
https://pubmed.ncbi.nlm.nih.gov/35968866

Zobrazit plný text záznamu